| Wilfred S Kearse Jr, MD | |
|
8851 Center Dr Ste 501, La Mesa, CA 91942-3033 | |
| (619) 697-2456 | |
| (858) 429-7930 |
| Full Name | Wilfred S Kearse Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 38 Years |
| Location | 8851 Center Dr Ste 501, La Mesa, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144232778 | NPI | - | NPPES |
| 00G833180 | Medicaid | CA | |
| CB307684 | Other | CA | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | G83318 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grossmont Hospital | La mesa, CA | Hospital |
| Sharp Memorial Hospital | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Healthcare Partners | 2163606807 | 185 |
News Archive
A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of the European Society of Human Genetics will hear today (Sunday 13 June). Dr. Zoltan Kutalik, from the Department of Medical Genetics, University of Lausanne, Switzerland, will tell delegates that individuals with this change, in a gene encoding for the antiviral cytokine (cell-signalling molecule) interferon lamda, reacts less well to treatment.
As part of its ongoing efforts to stop bogus health claims, the Federal Trade Commission has reached a settlement requiring major marketers of children's vitamins to stop making false and unproven claims that their supplements promote healthy brain and eye development in children. The companies have agreed to pay $2.1 million to provide refunds to consumers who purchased certain multivitamins in their Disney and Marvel Heroes line.
An implanted stimulator being studied at Thomas Jefferson University Hospital may be able to predict and prevent seizures before they start in people with uncontrolled epilepsy.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study evaluating resminostat (4SC-201), an oral pan-histone-deacetylase (HDAC) inhibitor in relapsed or refractory Hodgkin's Lymphoma (HL) patients.
The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). This fatal condition is a massive reaction of the body during which the lung becomes severely damaged. ARDS can be induced by various bacterial and viral infections, but also by chemical agents.
› Verified 8 days ago
| Entity Name | Genesis Healthcare Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548567498 PECOS PAC ID: 2163606807 Enrollment ID: O20110405000433 |
News Archive
A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of the European Society of Human Genetics will hear today (Sunday 13 June). Dr. Zoltan Kutalik, from the Department of Medical Genetics, University of Lausanne, Switzerland, will tell delegates that individuals with this change, in a gene encoding for the antiviral cytokine (cell-signalling molecule) interferon lamda, reacts less well to treatment.
As part of its ongoing efforts to stop bogus health claims, the Federal Trade Commission has reached a settlement requiring major marketers of children's vitamins to stop making false and unproven claims that their supplements promote healthy brain and eye development in children. The companies have agreed to pay $2.1 million to provide refunds to consumers who purchased certain multivitamins in their Disney and Marvel Heroes line.
An implanted stimulator being studied at Thomas Jefferson University Hospital may be able to predict and prevent seizures before they start in people with uncontrolled epilepsy.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study evaluating resminostat (4SC-201), an oral pan-histone-deacetylase (HDAC) inhibitor in relapsed or refractory Hodgkin's Lymphoma (HL) patients.
The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). This fatal condition is a massive reaction of the body during which the lung becomes severely damaged. ARDS can be induced by various bacterial and viral infections, but also by chemical agents.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wilfred S Kearse Jr, MD Po Box 33865, San Diego, CA 92163-3865 Ph: (858) 888-7700 | Wilfred S Kearse Jr, MD 8851 Center Dr Ste 501, La Mesa, CA 91942-3033 Ph: (619) 697-2456 |
News Archive
A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of the European Society of Human Genetics will hear today (Sunday 13 June). Dr. Zoltan Kutalik, from the Department of Medical Genetics, University of Lausanne, Switzerland, will tell delegates that individuals with this change, in a gene encoding for the antiviral cytokine (cell-signalling molecule) interferon lamda, reacts less well to treatment.
As part of its ongoing efforts to stop bogus health claims, the Federal Trade Commission has reached a settlement requiring major marketers of children's vitamins to stop making false and unproven claims that their supplements promote healthy brain and eye development in children. The companies have agreed to pay $2.1 million to provide refunds to consumers who purchased certain multivitamins in their Disney and Marvel Heroes line.
An implanted stimulator being studied at Thomas Jefferson University Hospital may be able to predict and prevent seizures before they start in people with uncontrolled epilepsy.
4SC AG, a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study evaluating resminostat (4SC-201), an oral pan-histone-deacetylase (HDAC) inhibitor in relapsed or refractory Hodgkin's Lymphoma (HL) patients.
The Spanish flu outbreak of 1918 killed between 30 and 50 million people. In the infected patients, the ultimate cause of death was acute respiratory distress syndrome (ARDS). This fatal condition is a massive reaction of the body during which the lung becomes severely damaged. ARDS can be induced by various bacterial and viral infections, but also by chemical agents.
› Verified 8 days ago
William Eugene Friedel, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 8851 Center Dr, Suite 502, La Mesa, CA 91942 Phone: 619-828-1000 Fax: 619-828-1001 | |
Dr. Carrie Aisen, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8881 Fletcher Pkwy Ste 250, La Mesa, CA 91942 Phone: 619-828-1000 | |
Scott Logan Brown, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8881 Fletcher Pkwy Ste 250, La Mesa, CA 91942 Phone: 619-828-1000 Fax: 619-828-1001 | |
Simon D. Wu, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8851 Center Drive, Suite 208, La Mesa, CA 91942 Phone: 619-828-1000 Fax: 619-828-1001 | |
Dr. Eileen Rebecca Byrne, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8881 Fletcher Pkwy Ste 250a, La Mesa, CA 91942 Phone: 619-229-2626 Fax: 619-286-5412 | |
Paul Edward Dato, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 8851 Center Dr, Suite 501, La Mesa, CA 91942 Phone: 619-697-2456 Fax: 619-697-2494 |